[引用][C] Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction
JM Pfeffer, TA Fischer, MA Pfeffer - Annual review of physiology, 1995 - annualreviews.org
Despite the trend for a decrease in fatality rates due to coronary heart disease,
hospitalizations for acute myocardial infarction and its long term sequelae have remained …
hospitalizations for acute myocardial infarction and its long term sequelae have remained …
Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study
P Vantrimpont, JL Rouleau, CC Wun, A Ciampi… - Journal of the American …, 1997 - jacc.org
Objectives. This study assessed whether treatment with a beta-adrenergic blocking agent in
addition to the use of the angiotensin-converting enzyme (ACE) inhibitor captopril decreases …
addition to the use of the angiotensin-converting enzyme (ACE) inhibitor captopril decreases …
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
Background Electrocardiographic markers of left ventricular hypertrophy (LVH) predict poor
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …
Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors.
P Gaudron, C Eilles, I Kugler, G Ertl - Circulation, 1993 - Am Heart Assoc
BACKGROUND Left ventricular enlargement and the development of chronic heart failure
are potent predictors of survival in patients after myocardial infarction. Prospective studies …
are potent predictors of survival in patients after myocardial infarction. Prospective studies …
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …
mortality and cardiovascular morbidity among patients with myocardial infarction …
Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiography substudy
B Greenberg, MA Quinones, C Koilpillai, M Limacher… - Circulation, 1995 - Am Heart Assoc
Background Studies of Left Ventricular Dysfunction (SOLVD) demonstrated that enalapril
therapy significantly improved the clinical course of patients with left ventricular (LV) …
therapy significantly improved the clinical course of patients with left ventricular (LV) …
Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice
XM Gao, AM Dart, E Dewar, G Jennings… - Cardiovascular …, 2000 - academic.oup.com
Objective: To test the usage of serial echocardiography in mice with induced myocardial
infarct (MI) and to characterize the mouse model of MI. Methods: C57 mice underwent open …
infarct (MI) and to characterize the mouse model of MI. Methods: C57 mice underwent open …
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic …
MA Konstam, MW Kronenberg, MF Rousseau… - Circulation, 1993 - Am Heart Assoc
BACKGROUND Patients with heart failure and reduced left ventricular (LV) ejection fraction
(EF) manifest progressive LV dilatation, which is prevented by angiotensin converting …
(EF) manifest progressive LV dilatation, which is prevented by angiotensin converting …
Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications
L Bolognese, AN Neskovic, G Parodi, G Cerisano… - Circulation, 2002 - Am Heart Assoc
Background—We prospectively evaluated the prevalence, pattern, and prognostic impact of
left ventricular (LV) remodeling after acute myocardial infarction (AMI) successfully treated …
left ventricular (LV) remodeling after acute myocardial infarction (AMI) successfully treated …
Impact of sacubitril/valsartan compared with ramipril on cardiac structure and function after acute myocardial infarction: the PARADISE-MI echocardiographic substudy
AM Shah, B Claggett, N Prasad, G Li, M Volquez… - Circulation, 2022 - Am Heart Assoc
Background: Angiotensin-converting enzyme inhibitors attenuate left ventricular (LV)
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …
enlargement after acute myocardial infarction (AMI). Preclinical data suggest similar benefits …